Treatment with 90Y/177Lu DOTATOC in patients with metastatic adrenocortical carcinoma expressing somatostatin receptors
Academic Article
Publication Date:
2019
Abstract:
We investigated the role of 68Ga-DOTATOC PET/CT in detecting somatostatin receptors (SSTRs) in 19 patients with metastatic adrenocortical carcinoma (ACC) and explored the activity of 90Y/177Lu-DOTATOC Peptide Receptor Radionuclide Therapy (PRRT).
CRIS type:
1.1 Articolo in rivista
Keywords:
Peptide Receptor Radionuclide Therapy (PRRT); adrenocortical carcinoma; metastases; somatostatin
List of contributors:
Grisanti, Salvatore; Filice, Angelina; Basile, Vittoria; Cosentini, Deborah; Rapa, Ida; Albano, Domenico; Morandi, Alessandra; Laganà , Marta; Dalla Volta, Alberto; Bertagna, Francesco; Tiberio, Guido M A; Volante, Marco; Terzolo, Massimo; Versari, Annibale; Berruti, Alfredo
Published in: